Colonoscopy Bowel Preparation

COLONOSCOPY BOWEL PREPARATION

Evidence-Based Protocols for Optimal Outcomes

Incorporating 2025 US Multi-Society Task Force Recommendations

LEARNING OBJECTIVES

Upon completion, the participant will be able to:

Explain the importance of adequate bowel preparation for colonoscopy quality and cancer detection

Compare split-dose vs. single-dose regimens and identify the 2025 USMSTF recommendations

Describe low-volume vs. high-volume preparation agents and appropriate patient selection

Identify patients at high risk for inadequate preparation and implement enhanced protocols

Apply evidence-based patient education strategies to optimize preparation adherence

Evaluate bowel preparation adequacy using standardized scoring systems (BBPS)

SECTION 1: IMPORTANCE OF BOWEL PREPARATION

Why Preparation Quality Matters

Adequate bowel preparation is the foundation of high-quality colonoscopy. The 2025 US Multi-Society Task Force on Colorectal Cancer emphasizes that inadequate preparation leads to: missed adenomas and cancers (up to 47% of lesions may be missed), need for repeat procedures at shorter intervals, increased procedure time and difficulty, higher sedation requirements, and increased costs for patients and healthcare systems.

2025 USMSTF QUALITY BENCHMARK: Bowel preparation adequacy rate of ≥90% is recommended at both individual endoscopist and endoscopy unit levels. This represents an increase from the prior 85% benchmark.

Boston Bowel Preparation Scale (BBPS)

The BBPS is the recommended standardized scoring system. Each segment (right, transverse, left) is scored 0-3:

Score 0: Unprepared - solid stool that cannot be cleared

Score 3: Excellent - entire mucosa clearly seen with no residue

SECTION 2: SPLIT-DOSE REGIMENS - THE NEW STANDARD

STRONG RECOMMENDATION (High-Quality Evidence): 'Use split-dose administration for all patients, regardless of preparation volume.' Split-dose regimens are superior to single-dose evening regimens for bowel cleanliness, adenoma detection, and patient tolerability.

Split-Dose Administration Protocol:

• First dose: Evening before procedure (typically 6-8 PM)

• Second dose: Morning of procedure, 4-6 hours before colonoscopy

• Complete second dose at least 2 hours before procedure time

SAME-DAY REGIMEN: Acceptable for afternoon colonoscopy (strong recommendation, high-quality evidence). Inferior for morning colonoscopy (weak recommendation, low-quality evidence). If same-day is used for morning procedures, start prep at least 5-6 hours before.

Low-Volume vs. High-Volume Preparations

2025 USMSTF RECOMMENDATION: 'Consider 2L bowel preparation regimens instead of 4L regimens.' (Weak recommendation, moderate-quality evidence). Low-volume preps offer comparable cleansing with better tolerability.

LOW-VOLUME OPTIONS (2L or less):

• SUPREP (sulfate-based): Two 6-oz doses, each followed by 32 oz water

• SUFLAVE (sulfate + PEG): Two doses, each in 16 oz water + 16 oz clear liquid

• MoviPrep (PEG + ascorbic acid): Two 1L doses + 1L clear liquid

• CLENPIQ (sodium picosulfate): Two small bottles, each followed by 40 oz liquid

• SUTAB (tablets): 24 tablets in two divided doses with water

HIGH-VOLUME OPTIONS (4L PEG):

• GoLYTELY, NuLYTELY, TriLyte: 4L PEG-electrolyte solution

• PREFERRED for: patients with renal impairment, heart failure, cirrhosis, electrolyte abnormalities

SECTION 3: SPECIAL POPULATIONS AND ENHANCED PROTOCOLS

Risk factors for inadequate preparation requiring enhanced protocols:

• Prior inadequate preparation (strongest predictor)

• Chronic constipation or infrequent bowel movements

• Chronic opioid use

• Diabetes mellitus (especially with autonomic neuropathy)

• Obesity (BMI >30)

• Neurological conditions (Parkinson's, stroke, dementia)

• Advanced age (>70 years)

• Male sex

• Tricyclic antidepressant use

ENHANCED PROTOCOLS for high-risk patients:

• Extended low-residue diet (2-3 days instead of 1 day)

• Addition of magnesium citrate as adjunct (day before)

• Consider higher volume preparation (4L PEG)

• Proactive phone/text reminder system

CONTRAINDICATIONS TO HYPEROSMOTIC (SULFATE-BASED) PREPS: Renal impairment (CrCl <30), heart failure, cirrhosis with ascites, electrolyte disturbances, bowel obstruction. Use PEG-based (iso-osmotic) preparations instead. (Strong recommendation, high-quality evidence)

Patient Education Strategies

Evidence-based education interventions shown to improve preparation quality:

• Written instructions WITH verbal reinforcement (not written alone)

• Visual aids showing clear vs. unclear stool output

• Phone calls or text reminders 2-3 days before and day before

• Patient navigation programs for high-risk patients

• Smartphone apps with reminders and visual guides

2025 USMSTF: 'Consider oral simethicone for bowel preparation' (weak recommendation, moderate evidence) - reduces bubbles that can obscure mucosa.

SECTION 4: DIETARY MODIFICATIONS

2025 USMSTF KEY CHANGE: Limiting diet modifications to the day before colonoscopy is acceptable. A low-residue diet (LRD) 1-2 days before, followed by clear liquids the day before, is sufficient for most patients. Extended dietary restrictions are generally unnecessary.

LOW-RESIDUE DIET (Day before procedure until clear liquid phase):

ALLOWED: White bread, eggs, lean meat/fish, white rice/pasta, well-cooked vegetables without skin, dairy (in moderation)

AVOID: Whole grains, raw vegetables, fruits with skin/seeds, nuts, seeds, popcorn, high-fiber foods

CLEAR LIQUID DIET (Day before and morning of procedure):

ALLOWED: Water, clear broth, tea/coffee (no milk), clear juices (apple, white grape), sports drinks, popsicles, gelatin (no red/purple)

AVOID: Red or purple liquids (can mimic blood), milk, cream, any opaque liquids

MEDICATION MANAGEMENT:

• Continue most medications until 2-4 hours before procedure

• Hold iron supplements 5-7 days before (causes dark stool)

• Anticoagulants: per gastroenterologist/cardiologist guidance

• Diabetes medications: specific instructions based on timing and agent